Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
64121
-
64122
-
64123
Temporal trends in adolescents’ self-reported psychosomatic health complaints from 1980-2016: A systematic review and meta-analysis
Published 2017“…In the descriptive analysis, 10 studies indicated a trend of increasing PSHC, eight showed a stable trend and three showed a decreasing trend at certain points in time. …”
-
64124
Table_1_FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the FMR1 Gene.docx
Published 2018“…<p>Fragile X syndrome (FXS) is mostly caused by two distinct events that occur in the FMR1 gene (Xq27.3): an expansion above 200 repeats of a CGG triplet located in the 5′UTR of the gene, and methylation of the cytosines located in the CpG islands upstream of the CGG repeats. …”
-
64125
DataSheet_1_A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.xls
Published 2022“…Objective<p>Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and the survival outcomes of patients with OS.…”
-
64126
DataSheet_3_A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.xls
Published 2022“…Objective<p>Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and the survival outcomes of patients with OS.…”
-
64127
DataSheet_2_A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.xls
Published 2022“…Objective<p>Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and the survival outcomes of patients with OS.…”
-
64128
-
64129
The Malnutrition-Related Increase in Early Visceralization of <i>Leishmania donovani</i> Is Associated with a Reduced Number of Lymph Node Phagocytes and Altered Conduit System Flo...
Published 2013“…<div><p>In a murine model of moderate childhood malnutrition we found that polynutrient deficiency led to a 4–5-fold increase in early visceralization of <i>L. donovani</i> (3 days post-infection) following cutaneous infection and a 16-fold decrease in lymph node barrier function (p<0.04 for all). …”
-
64130
Image_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64131
Image_4_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64132
Image_6_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64133
Table_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.pdf
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64134
Image_2_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64135
Image_3_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif
Published 2022“…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
-
64136
GdA’s effect on morphological variation differs in yeast strains possessing spontaneous mutations or recombinations, as compared to natural yeast isolates.
Published 2016“…(D) For the PC indicated by grey arrows in panels A–C, these plots display the average morphologies for each strain in GdA+ and GdA− conditions as well as the between-strain variation (blue and red bars), which decreases in GdA+ for MA and Rec lines but increases in other strain collections. …”
-
64137
Fetal Movement Counting Improved Identification of Fetal Growth Restriction and Perinatal Outcomes – a Multi-Centre, Randomized, Controlled Trial
Published 2011“…<div><h3>Background</h3><p>Fetal movement counting is a method used by the mother to quantify her baby's movements, and may prevent adverse pregnancy outcome by a timely evaluation of fetal health when the woman reports decreased fetal movements. …”
-
64138
-
64139
-
64140